A Peptidylic Inhibitor for Neutralizing (r)(GGGGCC)(exp)-Associated Neurodegeneration in C9ALS-FTD

One drug, two diseases is a rare and economical therapeutic strategy that is highly desirable in the pharmaceutical industry. We previously reported a 21-amino acid peptide named beta-structured inhibitor for neurodegenerative diseases (BIND) that can effectively inhibit expanded CAG trinucleotide t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qian, An, Ying, Chen, Zhefan Stephen, Koon, Alex Chun, Lau, Kwok-Fai, Ngo, Jacky Chi Ki, Chan, Ho Yin Edwin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424097/
https://www.ncbi.nlm.nih.gov/pubmed/30889483
http://dx.doi.org/10.1016/j.omtn.2019.02.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424097/
https://www.ncbi.nlm.nih.gov/pubmed/30889483
http://dx.doi.org/10.1016/j.omtn.2019.02.015

Ejemplares similares